TG Therapeutics, Inc. (TGTX) News
Filter TGTX News Items
TGTX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TGTX News Highlights
- For TGTX, its 30 day story count is now at 2.
- Over the past 8 days, the trend for TGTX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about TGTX are PAY, RS and TG.
Latest TGTX News From Around the Web
Below are the latest news stories about TG THERAPEUTICS INC that investors may wish to consider to help them evaluate TGTX as an investment opportunity.
11 Most Promising Biotech Stocks to Buy According to AnalystsIn this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Most Promising Biotech Stocks to Buy According to Analysts. The biotech industry is making a resurgence […] |
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS RatingTG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength. |
TG Therapeutics (NASDAQ:TGTX) grows 9.1% this week, taking five-year gains to 170%When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can... |
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ETNEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 6th Annual Evercore ISI HealthCONx Conference, being held at the Kimpton EPIC Hotel, in Miami, Florida on November 28 - 30, 2023. The fireside chat is scheduled to take place on Wednesday, November 29, 2023, at 2:10 PM ET. A live web |
Does TG Therapeutics (TGTX) Have the Potential to Rally 127.76% as Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 127.8% in TG Therapeutics (TGTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2023 Earnings Call TranscriptTG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Greetings, and welcome to the TG Therapeutics Third Quarter Earnings Update Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jenna Bosco. Thank you, Jenna. You may begin. Jenna Bosco: Thank […] |
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) ConferenceFireside chat scheduled for Monday, November 6, 2023, at 3:10 PM ETNEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference, being held at the JW Marriott Essex House, in New York City on November 6 -7, 2023. The fireside chat is scheduled to take place on Monday, November 6, 2023, at |
Why TG Therapeutics Stock Is Crushing It TodayShares of the biopharmaceutical company were soaring 36.4% higher as of 11:32 a.m. ET. Why were TG Therapeutics' Q3 results so good? CEO Michael Weiss said in the company's press release announcing its Q3 results that the sales figure for Briumvi "again exceeded our expectations." |
Morning Brew: AMD's Q4 Guidance Weighs on Stock, Apple's Negative Sentiment Overcooked, and FedAdvanced Micro Devices (NASDAQ:AMD) stock was among the most actively traded ahead of the opening bell, with shares down marginally. Wedbush Securities has a positive outlook on both Apple's (NASDAQ:AAPL) iPhone and services segments ahead of the companys fourth-quarter earnings report on Thursday. The research firm believes that the overall sentiment of Apple on the Street is a negative groupthink mentality, which is very disconnected from the current iPhone 15 growth. |
TG Therapeutics Inc (TGTX) Reports Third Quarter 2023 Financial ResultsTG Therapeutics Inc (NASDAQ:TGTX) reported a total net revenue of $165.8 million for Q3 2023, including BRIUMVI net sales of $25.1 million in the United States. The company has seen approximately 2,200 BRIUMVI prescriptions since its launch from over 500 healthcare providers across approximately 350 centers in the U.S. Payor coverage is in place for approximately 95% of covered lives for BRIUMVI. |